Microkeratomes go head-to-head with the femtosecond

Article

The M2 microkeratome (Moria), the Carriazo-Pendular microkeratome (Schwind) and the IntraLase femtosecond laser all create flaps of predictable thickness.

The M2 microkeratome (Moria), the Carriazo-Pendular microkeratome (Schwind) and the IntraLase femtosecond laser all create flaps of predictable thickness, according to a report published in the January issue of the Journal of Refractive Surgery.

Jorge Alió from Vissum/Instituto Oftalmológico de Alicante and David Piñero from Universidad Miguel Hernández, Alicante, Spain evaluated the corneal aberrometric outcomes and corneal flap thickness profiles following LASIK using three different devices for lamellar keratotomy. A total of 66 myopic eyes (33 patients) were enrolled and were randomly assigned to either of the two microkeratomes or the femtosecond laser. Intended flap thickness was 110 µm in all cases.

Mean central flap thickness was 117.50±7.80, 118.08±8.4 and 115.95±6.22 µm for the M2, Carriazo-Pendular and IntraLase systems, respectively. No significant differences were found among the groups. Nasal thickness was significantly larger for the M2 flaps compared with IntraLase (p<0.05) and Carriazo-Pendular flaps (p=0.046, only at 3 mm position). Temporal thicknesses were larger for the M2 flaps, although only differences between M2 and Carriazo-Pendular flaps reached statistical significance. Larger superior and inferior thicknesses were also observed for the M2 flaps, although no statistically significant differences were found. With regards to corneal aberrometry, no statistically significant differences were observed in coma-like (p=0.138) and spherical-like RMS (p=0.300).

Each of the three systems created predictable flap thicknesses and, furthermore, the Carriazo-Pendular and IntraLase devices created flaps with a planar profile.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
© 2025 MJH Life Sciences

All rights reserved.